About Aingo Pharma Private Limited
Data last updated:
Aingo Pharma Private Limited is a private limited company based in Manimajra, Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 September 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2013PTC034743. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ram Gopal and Sanjay Kumar Garg.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf – 32 Ground Floor Motor Market, Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.77 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹9.47 Lakh (net margin 1.4%) and EBITDA of ₹21.57 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 10% over five years.
The company is associated with 1 brand: Aingo Pharma. As per MCA filings, the company has open charges of ₹1.25 Cr and satisfied charges of ₹24 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aingopharma.com.
Company details
Contact details
Aingo Pharma Private Limited's registered office is in Manimajra, Chandigarh. Its website is aingopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressScf – 32 Ground Floor Motor Market, Manimajra, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aingo Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Aingo Pharma operates one associated brand: Aingo Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of powder, capsules, syrup, injectables, and tablets | aingopharma.in |
Business activity
The main business activity of Aingo Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aingo Pharma Private Limited, buy the company report.
Financials of Aingo Pharma Private Limited
FY 2025 filings availableAingo Pharma Private Limited reported revenue of ₹6.77 Cr (up 15% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 15% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21.57 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.47 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aingo Pharma Private Limited, buy the company report.
Board of directors of Aingo Pharma Private Limited
Aingo Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ram Gopal Also directs: Vlead Labs Private Limited | Director | 05 Dec 2014 | 11 Years 10 Months | Current |
| Sanjay Kumar Garg Also directs: Oasis Bio Bloom LLP, Dolvis Bio Pharma Private Limited, Vlead Labs Private Limited and 4 more | Director | 18 Aug 2014 | 12 Years 2 Months | Current |
Peer comparison
Aingo Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Estragen Pharma Private Limited | ₹6.8 Cr (FY 2025) | 2.0% | Jaipur, Rajasthan, India | |||
| Care Tech Life Science Private Limited | ₹6.78 Cr (FY 2025) | -14.0% | Bangalore, Karnataka, India | |||
| Aingo Pharma Private Limitedthis company | ₹6.77 Cr (FY 2024) | ₹9.47 Lakh | 1.4% | 15.0% | Manimajra, Chandigarh, India | |
| Dermarex Health Care India Private Limited | ₹6.74 Cr (FY 2024) | 11.0% | Coimbatore, Tamil Nadu, India |
To see the full peer comparison of Aingo Pharma Private Limited, buy the company report.
Auditor
Aingo Pharma Private Limited is audited by SHIV BANSAL & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHIV BANSAL & CO. | FY 2023 | 508111 |
Shareholding
The shareholding of Aingo Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aingo Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Apr 2024 | 100919953 | Others | ₹75 Lakh | Open | |
| 13 Oct 2023 | 100794507 | Others | ₹50 Lakh | Open | |
| 31 Jan 2017 | 100085094 | Hdfc Bank Limited | ₹24 Lakh | Satisfied |
To see the full charge records of Aingo Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Aingo Pharma Private Limited has 1 court case on record: 1 filed by Aingo Pharma. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against M/S Muthas Life Science | Disposed |
To see the full case history of Aingo Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aingo Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aingo Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Aingo Pharma Private Limited, buy the company report.
Recent activity
Aingo Pharma Private Limited has 7 board changes on record since 2014: 2 appointments and 5 cessations. The latest: Jeet Kumar Jain ceased to be Director on 09 Apr 2019.
2 earlier events are in the company report.
Frequently asked questions
Aingo Pharma is an active private limited company based in Manimajra, Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 September 2013 (13+ years old) and is registered under CIN U24232CH2013PTC034743.
Aingo Pharma has 2 current directors:
- Ram Gopal - Director
- Sanjay Kumar Garg - Director
The latest financial statements of Aingo Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Aingo Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Aingo Pharma is U24232CH2013PTC034743. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aingo Pharma has 1 court case on record: 1 filed by the company.
Aingo Pharma was incorporated on 25 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Aingo Pharma by revenue are Estragen Pharma Private Limited, Care Tech Life Science Private Limited, Dermarex Health Care India Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Jeet Kumar Jain ceased to be Director on 09 Apr 2019. Ram Gopal ceased to be Additional Director on 29 Sep 2018. Ram Gopal was appointed as Director on 05 Dec 2014. Aingo Pharma has 7 board changes on record in total.
Aingo Pharma can be reached through the website aingopharma.com. Its registered office is in Manimajra, Chandigarh, India.
The registered office of Aingo Pharma is at Scf – 32 Ground Floor Motor Market, Manimajra, Chandigarh, India – 160101.